|
1
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sayed D and Abdellatif M: MicroRNAs in
development and disease. Physiol Rev. 91:827–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan FY, Deng R, Yi H, Sun HP, Zeng Y, He
GC and Su Y: The inhibitory effect of MEG3/miR-214/AIFM2 axis on
the growth of T-cell lymphoblastic lymphoma. Int J Oncol.
51:316–326. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu M, Xue H, Wang Y, Shen Q, Jiang Q,
Zhang X, Li K, Jia M, Jia J, Xu J, et al: miR-345 inhibits tumor
metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT
pathway in hepatocellular carcinoma. Int J Oncol. 50:975–983. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He R, Yang L, Lin X, Chen X, Lin X, Wei F,
Liang X, Luo Y, Wu Y, Gan T, et al: MiR-30a-5p suppresses cell
growth and enhances apoptosis of hepatocellular carcinoma cells via
targeting AEG-1. Int J Clin Exp Pathol. 8:15632–15641. 2015.
|
|
6
|
Xie Z, Chen W, Chen Y, Wang X, Gao W and
Liu Y: miR-768-3p is involved in the proliferation, invasion and
migration of non-small cell lung carcinomas. Int J Oncol.
51:1574–1582. 2017. View Article : Google Scholar
|
|
7
|
Shang A, Yang M, Shen F, Wang J, Wei J,
Wang W, Lu W and Wang C and Wang C: MiR-1-3p suppresses the
proliferation, invasion and migration of bladder cancer cells by
up-regulating SFRP1 expression. Cell Physiol Biochem. 41:1179–1188.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen G, He M, Yin Y, Yan T, Cheng W, Huang
Z, Zhang L, Zhang H, Liu P, Zhu W, et al: miR-1296-5p decreases
ERBB2 expression to inhibit the cell proliferation in
ERBB2-positive breast cancer. Cancer Cell Int. 17:952017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding Y, Zhang C, Zhang J, Zhang N, Li T,
Fang J, Zhang Y, Zuo F, Tao Z, Tang S, et al: miR-145 inhibits
proliferation and migration of breast cancer cells by directly or
indirectly regulating TGF-β1 expression. Int J Oncol. 50:1701–1710.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiao G, Li X, Li G, Zhang B, Xu C, Qin S,
Du N, Wang J, Tang SC, Zhang J, et al: MiR-129 blocks estrogen
induction of NOTCH signaling activity in breast cancer stem-like
cells. Oncotarget. 8:103261–103273. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu X, Ma J, Chu J, Shao Q, Zhang Y, Lu G,
Li J, Huang X, Li W, Li Y, et al: MiR-129-5p sensitizes the
response of Her-2 positive breast cancer to trastuzumab by reducing
Rps6. Cell Physiol Biochem. 44:2346–2356. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jang MH, Kim HJ, Gwak JM, Chung YR and
Park SY: Prognostic value of microRNA-9 and microRNA-155 expression
in triple-negative breast cancer. Hum Pathol. 68:69–78. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang L, Xu Y, Jin X, Wang Z, Wu Y, Zhao
D, Chen G, Li D, Wang X, Cao H, et al: A circulating miRNA
signature as a diagnostic biomarker for non-invasive early
detection of breast cancer. Breast Cancer Res Treat. 154:423–434.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiong DD, Lv J, Wei KL, Feng ZB, Chen JT,
Liu KC, Chen G and Luo DZ: A nine-miRNA signature as a potential
diagnostic marker for breast carcinoma: An integrated study of
1,110 cases. Oncol Rep. 37:3297–3304. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tan X, Fu Y, Chen L, Lee W, Lai Y, Rezaei
K, Tabbara S, Latham P, Teal CB, Man YG, et al: miR-671-5p inhibits
epithelial-to-mesenchymal transition by downregulating FOXM1
expression in breast cancer. Oncotarget. 7:293–307. 2016.
|
|
16
|
Godfrey AC, Xu Z, Weinberg CR, Getts RC,
Wade PA, DeRoo LA, Sandler DP and Taylor JA: Serum microRNA
expression as an early marker for breast cancer risk in
prospectively collected samples from the Sister Study cohort.
Breast Cancer Res. 15:R422013. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gradishar WJ, Anderson BO, Balassanian R,
Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A,
Giordano SH, et al: Invasive Breast Cancer Version 1.2016, NCCN
Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw.
14:324–354. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen G, Rong M and Luo D: TNFRSF6B
neutralization antibody inhibits proliferation and induces
apoptosis in hepatocellular carcinoma cell. Pathol Res Pract.
206:631–641. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rong M, Chen G and Dang Y: Increased
miR-221 expression in hepatocellular carcinoma tissues and its role
in enhancing cell growth and inhibiting apoptosis in vitro. BMC
Cancer. 13:212013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rong M, He R, Dang Y and Chen G:
Expression and clinicopathological significance of miR-146a in
hepatocellular carcinoma tissues. Ups J Med Sci. 119:19–24. 2014.
View Article : Google Scholar :
|
|
21
|
Chen G, Kronenberger P, Teugels E and De
Grève J: Influence of RT-qPCR primer position on EGFR interference
efficacy in lung cancer cells. Biol Proced Online. 13:12010.
View Article : Google Scholar
|
|
22
|
Chen G, Umelo IA, Lv S, Teugels E, Fostier
K, Kronenberger P, Dewaele A, Sadones J, Geers C and De Grève J:
miR-146a inhibits cell growth, cell migration and induces apoptosis
in non-small cell lung cancer cells. PLoS One. 8:e603172013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen G, Kronenberger P, Teugels E, Umelo
IA and De Grève J: Effect of siRNAs targeting the EGFR T790M
mutation in a non-small cell lung cancer cell line resistant to
EGFR tyrosine kinase inhibitors and combination with various
agents. Biochem Biophys Res Commun. 431:623–629. 2013. View Article : Google Scholar
|
|
24
|
Xiao F, Lan A, Lin Z, Song J, Zhang Y, Li
J, Gu K, Lv B, Zhao D, Zeng S, et al: Impact of CAG repeat length
in the androgen receptor gene on male infertility - a
meta-analysis. Reprod Biomed Online. 33:39–49. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar
|
|
26
|
Phukan JP, Sinha A and Deka JP:
Cytological grading of breast carcinoma on fine needle aspirates
and its relation with histological grading. South Asian J Cancer.
4:32–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chavez-MacGregor M, Mittendorf EA, Clarke
CA, Lichtensztajn DY, Hunt KK and Giordano SH: Incorporating tumor
characteristics to the American Joint Committee on Cancer Breast
Cancer Staging System. Oncologist. 22:1292–1300. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fassan M, Baffa R, Palazzo JP, Lloyd J,
Crosariol M, Liu CG, Volinia S, Alder H, Rugge M, Croce CM, et al:
MicroRNA expression profiling of male breast cancer. Breast Cancer
Res. 11:R582009. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao H, Shen J, Medico L, Wang D,
Ambrosone CB and Liu S: A pilot study of circulating miRNAs as
potential biomarkers of early stage breast cancer. PLoS One.
5:e137352010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Romero-Cordoba S, Rodriguez-Cuevas S,
Rebollar-Vega R, Quintanar-Jurado V, Maffuz-Aziz A, Jimenez-Sanchez
G, Bautista-Piña V, Arellano-Llamas R and Hidalgo-Miranda A:
Identification and pathway analysis of microRNAs with no previous
involvement in breast cancer. PLoS One. 7:e319042012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gravgaard KH, Lyng MB, Laenkholm AV,
Søkilde R, Nielsen BS, Litman T and Ditzel HJ: The miRNA-200 family
and miRNA-9 exhibit differential expression in primary versus
corresponding metastatic tissue in breast cancer. Breast Cancer Res
Treat. 134:207–217. 2012. View Article : Google Scholar
|
|
32
|
Biagioni F, Bossel Ben-Moshe N, Fontemaggi
G, Canu V, Mori F, Antoniani B, Di Benedetto A, Santoro R, Germoni
S, De Angelis F, et al: miR-10b*, a master inhibitor of the cell
cycle, is down-regulated in human breast tumours. EMBO Mol Med.
4:1214–1229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schrauder MG, Strick R, Schulz-Wendtland
R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A,
Hein A, et al: Circulating micro-RNAs as potential blood-based
markers for early stage breast cancer detection. PLoS One.
7:e297702012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yan M, Shield-Artin K, Byrne D, Deb S,
Waddell N, Haviv I and Fox SB; kConFab Investigators, kConFab:
Comparative microRNA profiling of sporadic and BRCA1 associated
basal- like breast cancers. BMC Cancer. 15:5062015. View Article : Google Scholar
|
|
35
|
Feliciano A, Castellvi J, Artero-Castro A,
Leal JA, Romagosa C, Hernández-Losa J, Peg V, Fabra A, Vidal F,
Kondoh H, et al: miR-125b acts as a tumor suppressor in breast
tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and
MEGF9. PLoS One. 8:e762472013. View Article : Google Scholar
|
|
36
|
Matamala N, Vargas MT, González-Cámpora R,
Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G,
Yanowsky K, Calvete-Candenas J, et al: Tumor microRNA expression
profiling identifies circulating microRNAs for early breast cancer
detection. Clin Chem. 61:1098–1106. 2015. View Article : Google Scholar
|
|
37
|
Zeng JH, Liang L, He RQ, Tang RX, Cai XY,
Chen JQ, Luo DZ and Chen G: Comprehensive investigation of a novel
differentially expressed lncRNA expression profile signature to
assess the survival of patients with colorectal adenocarcinoma.
Oncotarget. 8:16811–16828. 2017.
|
|
38
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schnitt SJ: Classification and prognosis
of invasive breast cancer: From morphology to molecular taxonomy.
Mod Pathol. 23(Suppl 2): S60–S64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Song C, Zhang L, Wang J, Huang Z, Li X, Wu
M, Li S, Tang H and Xie X: High expression of microRNA-183/182/96
cluster as a prognostic biomarker for breast cancer. Sci Rep.
6:245022016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Marino AL, Evangelista AF, Vieira RA,
Macedo T, Kerr LM, Abrahão-Machado LF, Longatto-Filho A, Silveira
HC and Marques MM: MicroRNA expression as risk biomarker of breast
cancer metastasis: A pilot retrospective case-cohort study. BMC
Cancer. 14:7392014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sun L, Liu T, Zhang S, Guo K and Liu Y:
Oct4 induces EMT through LEF1/β-catenin dependent WNT signaling
pathway in hepatocellular carcinoma. Oncol Lett. 13:2599–2606.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yanaka Y, Muramatsu T, Uetake H, Kozaki K
and Inazawa J: miR-544a induces epithelial-mesenchymal transition
through the activation of WNT signaling pathway in gastric cancer.
Carcinogenesis. 36:1363–1371. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jin B, Wang W, Meng XX, Du G, Li J, Zhang
SZ, Zhou BH and Fu ZH: Let-7 inhibits self-renewal of
hepatocellular cancer stem-like cells through regulating the
epithelial-mesenchymal transition and the Wnt signaling pathway.
BMC Cancer. 16:8632016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu ZJ, Liu HL, Zhou HC and Wang GC: TIPE2
Inhibits Hypoxia-induced Wnt/β-catenin pathway activation and EMT
in glioma cells. Oncol Res. 24:255–261. 2016. View Article : Google Scholar
|
|
46
|
Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan
J, Wu J and Li M: MicroRNA-374a activates Wnt/β-catenin signaling
to promote breast cancer metastasis. J Clin Invest. 123:566–579.
2013.PubMed/NCBI
|
|
47
|
Xiao C, Wu CH and Hu HZ: LncRNA UCA1
promotes epithelial-mesenchymal transition (EMT) of breast cancer
cells via enhancing Wnt/beta-catenin signaling pathway. Eur Rev Med
Pharmacol Sci. 20:2819–2824. 2016.PubMed/NCBI
|
|
48
|
Xiao G, Zhang B, Meng J, Wang J, Xu C,
Tang SC, Li X, Zhang J, Liang R, Ren H, et al: miR-367 stimulates
Wnt cascade activation through degrading FBXW7 in NSCLC stem cells.
Cell Cycle. 16:2374–2385. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Fasihi A, M Soltani B, Atashi A and Nasiri
S: Introduction of hsa-miR-103a and hsa-miR-1827 and hsa-miR-137 as
new regulators of Wnt signaling pathway and their relation to
colorectal carcinoma. J Cell Biochem. Aug 17–2017.Epub ahead of
print. PubMed/NCBI
|
|
50
|
Zhang W, Shen C, Li C, Yang G, Liu H, Chen
X, Zhu D, Zou H, Zhen Y, Zhang D, et al: miR-577 inhibits
glioblastoma tumor growth via the Wnt signaling pathway. Mol
Carcinog. 55:575–585. 2016. View Article : Google Scholar
|
|
51
|
Yi SJ, Li LL and Tu WB: MiR-214 negatively
regulates proliferation and WNT/β-catenin signaling in breast
cancer. Eur Rev Med Pharmacol Sci. 20:5148–5154. 2016.
|
